Portfolio

Rejuvenate Bio Launches

By Wyss Institute

February 7, 2020

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Rejuvenate Bio has secured an exclusive worldwide license from the Harvard Office of Technology Development to commercialize a gene therapy technology developed at the Wyss Institute and Harvard Medical School (HMS) to prevent and treat several age-related diseases in dogs, extending their overall healthspan. The announcement follows the publication in Proceedings of the National Academy of Arts and Sciences (PNAS) of a study led by Harvard researchers detailing the technology’s efficacy in mitigating obesity, type II diabetes, heart failure, and renal failure in mice.